Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ATHEROREMO

Financiado

Cerrado

European Collaborative Project on Inflamation and Vascular Wall Remodelling in A...

European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis The health of the EC population has never been better. However, serious public health problems remain, which cannot be ignored including high levels of premature death due to cardiovascular diseases. Thus, new preventive, diagnost... ver más

31/10/2013

Tampere University...

15M€

Presupuesto del proyecto: 15M€

Líder del proyecto

PIRKANMAA HOSPITAL DISTRICT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 18 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-10-31 No tenemos la información de la convocatoria

0% 76% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

18 Participantes

Tampere University Hospital

0.00€ | Lider

VTT

N.D. | Participante

HVL

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ATHEROMOTO Vascular inflammation and atherosclerosis 240K€ Cerrado

SAF2016-80843-R ANALISIS DE MEDIADORES Y DIANAS TERAPEUTICAS IMPLICADAS EN E... 194K€ Cerrado

PID2019-106773RB-I00 LA RESPUESTA INMUNE HUMORAL DURANTE LA ATEROSCLEROSIS 339K€ Cerrado

InflammaTENSION A study of the roles of the immune and inflammatory systems... 2M€ Cerrado

SAF2013-42962-R NUEVAS DIANAS DE INHIBICION DE LA TRANSFORMACION DE ATEROSCL... 460K€ Cerrado

PRE2021-099009 NOVEL MECHANISMS OF ATHEROSCLEROSIS 101K€ Cerrado

Líder del proyecto

PIRKANMAA HOSPITAL DISTRICT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 15M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The health of the EC population has never been better. However, serious public health problems remain, which cannot be ignored including high levels of premature death due to cardiovascular diseases. Thus, new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases are needed. The atherosclerotic changes of the vascular wall are central in the development of cardiovascular complications. The traditional view that atherosclerosis is simply a lipid storage disease has recently been challenged by evidence that inflammation plays a central role in all stages of atherosclerosis. However, molecular mechanisms linking inflammation to atherosclerosis development are not fully understood, and this has severely hampered the advance of diagnostic and therapeutic programs. AtheroRemo aims to identify novel inflammatory mechanisms in vascular remodelling by combining the exploration of human biobanks with animal models and established cellular models. This new knowledge will be used to develop new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular disease. AtheroRemo contains several unique strengths: 1) Outstanding expertise on immunity and inflammation. Our expertise facilitates the breakthroughs in the immuno-inflammatory targeted vascular treatments. 2) Finest European cohorts to search for molecular mechanisms behind atherosclerosis development allowing us to combine underlying genetics with lipidomic profiles in multiple cohorts in order to obtain risk factors and biomarker panel related to inflammatory remodelling. 3) Accelerated target validation with novel liposomal-targeted delivery of nucleic acid-based therapeutics in appropriate animal models. Four SME partners able to exploit the new knowledge support AtheroRemo research. Thus, we expect to translate a number of novel findings into potential clinical applications such as new diagnostic tools (biomarkers) and therapeutics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores